Recombinant Human OCIA Domain Containing 2
Shipping Info:
For estimated delivery dates, please contact us at [email protected]
| Amount : | 20 µg |
| Purification : | Greater than 85.0% as determined by SDS-PAGE. |
| Content : | OCIAD2 protein solution (0.5mg/ml) containing 20mM Tris-HCl buffer (pH 8.0), 0.4M UREA and 10% glycerol. |
| Storage condition : | Store at 4°C if entire vial will be used within 2-4 weeks. Store, frozen at -20°C for longer periods of time. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).Avoid multiple freeze-thaw cycles. |
| AA sequence : | MGSSHHHHHH SSGLVPRGSH MGSMASASAR GNQDKDAHFP PPSKQSLLFC PKSKLHIHRA EISKIMRECQ EESFWKRALP FSLVSMLVTQ GLVYQGYLAA NSRFGSLPKV ALAGLLGFGL GKVSYIGVCQ SKFHFFEDQL RGAGFGPQHN RHCLLTCEEC KIKHGLSEKG DSQPSAS |
| Alternative Name : | OCIA domain-containing protein 2, Ovarian carcinoma immunoreactive antigen-like protein, OCIAD2. |
Source : Escherichia Coli.
OCIAD2 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 177 amino acids (1-154 a.a) and having a molecular mass of 19.3kDa.OCIAD2 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.
OCIA domain-containing protein 2 (OCIAD2) is a protein-coding gene which localizes to endosomes and contains one Ovarian carcinoma immunoreactive antigen (OCIA) domain. Among the associated diseases with OCIAD2 are bronchiolo-alveolar adenocarcinoma, and ovarian mucinous neoplasm. OCIAD1 is an important paralog of this gene.
For Research Use Only. Not for use in diagnostic/therapeutics procedures.
|
There are currently no product reviews
|
.png "ACE2/HEK293 Stable Cell Line")
